Hyperion Therapeutics Inc (NASDAQ:HPTX)

46.00
Delayed Data
As of May 05
 +0.01 / +0.02%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.67%
Year-to-Date
No recent news for Hyperion Therapeutics Inc.

Today’s Trading

Previous close45.99
Today’s open46.00
Day’s range-- - --
Volume327,451
Average volume (3 months)544,286
Market cap$964.7M
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)-138.75%
Earnings growth (this year)+349.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+169.13%
P/E ratioNM
Price/Sales4.33
Price/Book7.25

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.57-8.05%
ZFGNZafgen Inc-2.70-7.86%
RGENRepligen Corp-0.02-0.06%
MGNXMacroGenics Inc-2.56-8.61%
Data as of 05/05/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$113.6M
Annual profit (last year)-$6.3M
Net profit margin-5.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers